2,5-Dimethoxy-4-methylamphetamine

DOM
Chemical name	2,5-dimethoxy-4-methylamphetamine or 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane
Chemical formula	C12H19NO2
Molecular mass	209.29 g/mol
Melting point	61 °C
CAS numbers	315588-95-1, 26011-50-7, 43061-13-8, 43061-14-9
SMILES	N[C@H](C)CC1=C(OC)C=C(C)C(OC)=C1 (R-isomer)

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

WikiDoc Resources for 2,5-Dimethoxy-4-methylamphetamine
Articles
Most recent articles on 2,5-Dimethoxy-4-methylamphetamine Most cited articles on 2,5-Dimethoxy-4-methylamphetamine Review articles on 2,5-Dimethoxy-4-methylamphetamine Articles on 2,5-Dimethoxy-4-methylamphetamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on 2,5-Dimethoxy-4-methylamphetamine Images of 2,5-Dimethoxy-4-methylamphetamine Photos of 2,5-Dimethoxy-4-methylamphetamine Podcasts & MP3s on 2,5-Dimethoxy-4-methylamphetamine Videos on 2,5-Dimethoxy-4-methylamphetamine
Evidence Based Medicine
Cochrane Collaboration on 2,5-Dimethoxy-4-methylamphetamine Bandolier on 2,5-Dimethoxy-4-methylamphetamine TRIP on 2,5-Dimethoxy-4-methylamphetamine
Clinical Trials
Ongoing Trials on 2,5-Dimethoxy-4-methylamphetamine at Clinical Trials.gov Trial results on 2,5-Dimethoxy-4-methylamphetamine Clinical Trials on 2,5-Dimethoxy-4-methylamphetamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on 2,5-Dimethoxy-4-methylamphetamine NICE Guidance on 2,5-Dimethoxy-4-methylamphetamine NHS PRODIGY Guidance FDA on 2,5-Dimethoxy-4-methylamphetamine CDC on 2,5-Dimethoxy-4-methylamphetamine
Books
Books on 2,5-Dimethoxy-4-methylamphetamine
News
2,5-Dimethoxy-4-methylamphetamine in the news Be alerted to news on 2,5-Dimethoxy-4-methylamphetamine News trends on 2,5-Dimethoxy-4-methylamphetamine
Commentary
Blogs on 2,5-Dimethoxy-4-methylamphetamine
Definitions
Definitions of 2,5-Dimethoxy-4-methylamphetamine
Patient Resources / Community
Patient resources on 2,5-Dimethoxy-4-methylamphetamine Discussion groups on 2,5-Dimethoxy-4-methylamphetamine Patient Handouts on 2,5-Dimethoxy-4-methylamphetamine Directions to Hospitals Treating 2,5-Dimethoxy-4-methylamphetamine Risk calculators and risk factors for 2,5-Dimethoxy-4-methylamphetamine
Healthcare Provider Resources
Symptoms of 2,5-Dimethoxy-4-methylamphetamine Causes & Risk Factors for 2,5-Dimethoxy-4-methylamphetamine Diagnostic studies for 2,5-Dimethoxy-4-methylamphetamine Treatment of 2,5-Dimethoxy-4-methylamphetamine
Continuing Medical Education (CME)
CME Programs on 2,5-Dimethoxy-4-methylamphetamine
International
2,5-Dimethoxy-4-methylamphetamine en Espanol 2,5-Dimethoxy-4-methylamphetamine en Francais
Business
2,5-Dimethoxy-4-methylamphetamine in the Marketplace Patents on 2,5-Dimethoxy-4-methylamphetamine
Experimental / Informatics
List of terms related to 2,5-Dimethoxy-4-methylamphetamine

Overview

DOM (or STP, allegedly standing for Serenity, Tranquillity and Peace, but based on the name of STP (motor oil company) and thus named by Owsley Stanley) is a psychedelic hallucinogenic drug and a substituted amphetamine of the phenethylamine class of compounds, sometimes used as an entheogen. DOM was first synthesized by Alexander Shulgin. The full name of the chemical is 4-methyl-2,5-dimethoxyamphetamine. DOM has a stereocenter and R-(-)-DOM is the more active stereoisomer. In his book PIHKAL (Phenethylamines I Have Known and Loved), Shulgin lists the dosage range as 3 to 10 mg. DOM is generally taken orally. DOM is classified as a Schedule I substance in the United States, and is similarly controlled in other parts of the world. Internationally, DOM is a Schedule I drug under the Convention on Psychotropic Substances.

Not much information is known about the toxicity of DOM. According to Shulgin, the effects of DOM typically last 14 to 20 hours. Clinical studies have indicated that repeated exposures to DOM can result in the rapid development of tolerance in as little as three days.

In mid-1967, tablets containing 20mg (later 10mg) of DOM were widely distributed in the Haight-Ashbury District of San Francisco under the name of STP. This short-lived appearance of DOM on the black market proved disastrous for several reasons. First, the tablets contained an excessively high dose of the chemical. This, combined with DOM’s slow onset of action (which encouraged some users, familiar with drugs that have quicker onsets, such as LSD, to re-dose) and its remarkably long duration, caused many users to panic and sent some to the emergency room. Second, treatment of such overdoses was complicated by the fact that no one at the time knew that the tablets called STP were, in fact, DOM.

Another structural isomer of DOM is also known to be active. This compound has the methoxy groups at the 2,6 positions instead, and is known as Ψ-DOM.

See also

• Phenethylamines
• DOB
• DOI

External links

• DOM Entry in PIHKAL
• Erowid DOM Vault